Position
Fidelity in ImmunityBio, Inc.
Back to the book · All holders of IBRX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $32K$7.67 → $8.75
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 13.6K | $26.9K | — | — | — | 0.0% |
| Q1 2026 | 30.7K | $235.5K | $7.67 | $77.3K | $131.3K | 0.0% |
| Q2 2026 | 29.5K | $258.2K | $8.75 | $32K | −$9.29K | 0.0% |